R21CA279773
Project Grant
Overview
Grant Description
Regulation of glioblastoma cells by GABAergic neurons in human organoid-tumor chimeras - project summary/abstract
Glioblastoma (GBM, WHO grade IV glioma) is one of the most common and deadliest primary brain tumors that affects both children and adults. GBM is associated with significantly elevated mortality, and there are no effective therapies available for patients despite many previous clinical trials.
It is believed that a better understanding of the cell types and factors regulating GBM cell properties in the brain could provide novel insights into the pathology and reveal new therapeutic targets for treating GBM patients.
The main goal of this R21 proposal is to elucidate the role of human GABAergic neurons in regulating the proliferation and survival of GBM cells in the brain using an innovative co-culture approach of human GBM spheroids and human induced pluripotent stem cell (iPSC)-derived telencephalic organoids (organoid-GBM chimeras).
To achieve this goal, we will use the most advanced neuroscience tools and techniques, including human stem cell-derived brain organoids, optogenetics, rabies virus tracing, and single-cell RNA sequencing, to characterize the communication between GABAergic neurons and tumor cells in organoid-GBM chimeras and the effects of this communication on tumor cell survival and proliferation.
Our specific hypothesis is that GABAergic neurons form functional synapses with tumor cells in GBM-organoid chimeras to promote tumor cell proliferation or survival via GABA-mediated depolarization of tumor cells.
The specific aims to test this hypothesis are:
(1) To determine whether GABAergic neurons establish functional synapses with GBM cells to regulate tumor growth and survival.
(2) To determine the role of trans-synaptic signaling proteins in regulating tumor growth and survival.
Overall, we expect that this study will advance our understanding of the cellular and molecular mechanisms involved in the regulation of GBM cell properties in the human brain and provide a novel framework for studying the interactions of human brain tumors with human neurons in a human brain-like environment.
Glioblastoma (GBM, WHO grade IV glioma) is one of the most common and deadliest primary brain tumors that affects both children and adults. GBM is associated with significantly elevated mortality, and there are no effective therapies available for patients despite many previous clinical trials.
It is believed that a better understanding of the cell types and factors regulating GBM cell properties in the brain could provide novel insights into the pathology and reveal new therapeutic targets for treating GBM patients.
The main goal of this R21 proposal is to elucidate the role of human GABAergic neurons in regulating the proliferation and survival of GBM cells in the brain using an innovative co-culture approach of human GBM spheroids and human induced pluripotent stem cell (iPSC)-derived telencephalic organoids (organoid-GBM chimeras).
To achieve this goal, we will use the most advanced neuroscience tools and techniques, including human stem cell-derived brain organoids, optogenetics, rabies virus tracing, and single-cell RNA sequencing, to characterize the communication between GABAergic neurons and tumor cells in organoid-GBM chimeras and the effects of this communication on tumor cell survival and proliferation.
Our specific hypothesis is that GABAergic neurons form functional synapses with tumor cells in GBM-organoid chimeras to promote tumor cell proliferation or survival via GABA-mediated depolarization of tumor cells.
The specific aims to test this hypothesis are:
(1) To determine whether GABAergic neurons establish functional synapses with GBM cells to regulate tumor growth and survival.
(2) To determine the role of trans-synaptic signaling proteins in regulating tumor growth and survival.
Overall, we expect that this study will advance our understanding of the cellular and molecular mechanisms involved in the regulation of GBM cell properties in the human brain and provide a novel framework for studying the interactions of human brain tumors with human neurons in a human brain-like environment.
Awardee
Funding Goals
TO PROVIDE FUNDAMENTAL INFORMATION ON THE CAUSE AND NATURE OF CANCER IN PEOPLE, WITH THE EXPECTATION THAT THIS WILL RESULT IN BETTER METHODS OF PREVENTION, DETECTION AND DIAGNOSIS, AND TREATMENT OF NEOPLASTIC DISEASES. CANCER BIOLOGY RESEARCH INCLUDES THE FOLLOWING RESEARCH PROGRAMS: CANCER CELL BIOLOGY, CANCER IMMUNOLOGY, HEMATOLOGY AND ETIOLOGY, DNA AND CHROMOSOMAL ABERRATIONS, TUMOR BIOLOGY AND METASTASIS, AND STRUCTURAL BIOLOGY AND MOLECULAR APPLICATIONS.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Utah
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 79% from $215,811 to $386,799.
University Of Utah was awarded
Project Grant R21CA279773
worth $386,799
from National Cancer Institute in April 2023 with work to be completed primarily in Utah United States.
The grant
has a duration of 2 years and
was awarded through assistance program 93.396 Cancer Biology Research.
The Project Grant was awarded through grant opportunity Neural Regulation of Cancer (R21 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 6/20/25
Period of Performance
4/6/23
Start Date
3/31/25
End Date
Funding Split
$386.8K
Federal Obligation
$0.0
Non-Federal Obligation
$386.8K
Total Obligated
Activity Timeline
Transaction History
Modifications to R21CA279773
Additional Detail
Award ID FAIN
R21CA279773
SAI Number
R21CA279773-2031182977
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NC00 NIH National Cancer Institute
Awardee UEI
LL8GLEVH6MG3
Awardee CAGE
3T624
Performance District
UT-90
Senators
Mike Lee
Mitt Romney
Mitt Romney
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $215,811 | 100% |
Modified: 6/20/25